Michael Vazquez

Michael Vazquez

Company: Lynk Pharmaceuticals

Job title: Executive Vice President, Head of Chemistry, Co-Founder


Everyone Is Talking About JAK Inhibitors: Addressing Safety in Dermatology 10:30 am

As JAK inhibitors bring a level of efficacy unseen previously for Atopic Dermatitis, and Incyte’s Phase II in Hidradenitis Suppurativa reinforce the safety of the selective JAK1/ JAK2 inhibitor topical cream, is this enough to overcome the black box warning of 2021, or are dermatologists still wary of using this modality due to safety concerns?…Read more

day: Pre-Conference Workshops

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.